Apace KY recalls Acyclovir tablets with possible Torsemide tablets
Apace KY recalls Acyclovir tablets that may contain Torsemide tablets in some blister cavities. This could cause unintended medication effects.
Lower-risk recall
Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.
Contact the company
What happened, in plain English
Apace KY is recalling Acyclovir tablets that may contain Torsemide tablets in some blister cavities. This could cause unintended medication effects if taken. Read more at govinfonow.com/recall/40845-apace-ky-recalls-acyclovir-tablets-with-possible-torsemide-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/40845-apace-ky-recalls-acyclovir-tablets-with-possible-torsemide-tablets · Updated October 7, 2026 · FDA enforcement record: FDA #D-0544-2018
Cite this page
“Apace KY recalls Acyclovir tablets with possible Torsemide tablets.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40845-apace-ky-recalls-acyclovir-tablets-with-possible-torsemide-tablets. Based on FDA recall #D-0544-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0544-2018%22&limit=1).
Why it’s dangerous
The cartons labeled as containing Acyclovir tablets may have Torsemide tablets in some blister cavities. Torsemide is a different medication that could cause unintended effects if taken with Acyclovir.
Who’s affected
People who have the recalled Acyclovir tablets (400 mg, 50 tablets per carton) and are prescribed this medication. Those with kidney issues or taking other medications may be at higher risk.
How to tell if you have this one
Check for the product name 'Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters' with NDC 50268-061-11 per carton NDC 50268-061-15. The product is prescription-only and manufactured for AvKARE, Inc.
- Brand
Apace KY- Category
Drug
What to do — step by step
Check Product
Look for the product name and NDC numbers on the packaging to confirm if it's the recalled item.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0544-2018 (February 9, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0544-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.